Human PTPRN (Receptor-Type Tyrosine-Protein Phosphatase-Like N) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-04520P

SDS-PAGE analysis of Human PTPRN (Receptor-Type Tyrosine-Protein Phosphatase-Like N) - Recombinant Protein, CAT# BLT-04520P, showing >85% purity under 15% SDS-PAGE (Reduced)
Human PTPRN (Receptor-Type Tyrosine-Protein Phosphatase-Like N) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-04520P
Regular price
$59500
$595.00
Sale price$44500
$445.00Save $150
/
Quantity Pricing
Pack Size | Price (USD) |
---|---|
500 µg | $1,030 (Fall Promotion) |
1 mg | $1,870 (Fall Promotion) |
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
Product Name | Recombinant Human Tyrosine Phosphatase Receptor Type N (PTPRN) Protein |
Product Overview | This recombinant human Tyrosine Phosphatase Receptor Type N (PTPRN) protein includes amino acids 185-367aa of the target gene is expressed in E.coli.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
Target Uniprot Id | Q16849 |
Recommended Name | Receptor-type tyrosine-protein phosphatase-like N |
Gene Name | PTPRN |
Synonyms | Receptor-type tyrosine-protein phosphatase-like N; R-PTP-N; Islet cell antigen 512; ICA 512; Islet c |
Species | Human |
Predicted Molecular Mass | 23 kDa |
Expression System | E.coli |
Expression Range | 185-367aa |
Tag | N-6His |
Purity | >85% |
Formulation | Lyophilized |
Buffer | Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
Applications | Positive Control; Immunogen; SDS-PAGE; WB |
Research Area | Signal Transduction |
Target Function | Plays a role in vesicle-mediated secretory processes. Required for normal accumulation of secretory vesicles in hippocampus, pituitary and pancreatic islets. Required for the accumulation of normal levels of insulin-containing vesicles and preventing their degradation. Plays a role in insulin secretion in response to glucose stimuli. Required for normal accumulation of the neurotransmitters norepinephrine, dopamine and serotonin in the brain. In females, but not in males, required for normal accumulation and secretion of pituitary hormones, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Required to maintain normal levels of renin expression and renin release. Seems to lack intrinsic enzyme activity. May regulate catalytic active protein-tyrosine phosphatases such as PTPRA through dimerization.; ICA512-TMF regulates dynamics and exocytosis of insulin secretory granules (SGs); binding of ICA512-TMF to SNTB2/beta-2-syntrophin is proposed to restrain SGs mobility and exocytosis by tethering them to the actin cytoskeleton depending on UTRN; the function is inhibited by cytoplasmic ICA512-CFF dimerizing with ICA512-TMF and displacing SNTB2.; ICA512-CCF translocated to the nucleus promotes expression of insulin and other granule-related genes; the function implicates binding to and regulating activity of STAT5B probably by preventing its dephosphorylation and potentially by inducing its sumoylation by recruiting PIAS4. Enhances pancreatic beta-cell proliferation by converging with signaling by STAT5B and STAT3. ICA512-CCF located in the cytoplasm regulates dynamics and exocytosis of insulin secretory granules (SGs) by dimerizing with ICA512-TMF and displacing SNTB2 thus enhancing SGs mobility and exocytosis. |
Subcellular Location | Membrane; Single-pass type I membrane protein. Cytoplasmic vesicle, secretory vesicle membrane; Single-pass type I membrane protein. Perikaryon. Cell projection, axon. Cell junction, synapse. Cell membrane; Single-pass type I membrane protein. Endosome.; [ICA512-transmembrane fragment]: Cytoplasmic vesicle, secretory vesicle membrane.; [ICA512-cleaved cytosolic fragment]: Nucleus. |
Protein Family | Protein-tyrosine phosphatase family, Receptor class 8 subfamily |
Associated Diseases | Autoantigen in insulin-dependent diabetes mellitus (IDDM). |
Tissue Specificity | Expression is restricted to neuroendocrine cells. Found in pancreas, brain and pituitary. |